2015
DOI: 10.1016/j.vaccine.2014.12.061
|View full text |Cite
|
Sign up to set email alerts
|

Increasing cellular immunogenicity to peptide-based vaccine candidates using a fluorocarbon antigen delivery system

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
4
1
1

Relationship

2
4

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 20 publications
0
6
0
Order By: Relevance
“…Sequentially conserved epitopes, which are generally less exposed, can elicit antibodies that are broadly cross reactive [36,37]. In recent years, small peptides corresponding to conserved epitopes of antibodies have been considered as potential vaccine candidates [32,38]. In this study we characterized the conserved linear epitope specificity of NAbs potentially involved in spontaneous viral clearance by detecting the reactivity of the serum samples…”
Section: Discussionmentioning
confidence: 99%
“…Sequentially conserved epitopes, which are generally less exposed, can elicit antibodies that are broadly cross reactive [36,37]. In recent years, small peptides corresponding to conserved epitopes of antibodies have been considered as potential vaccine candidates [32,38]. In this study we characterized the conserved linear epitope specificity of NAbs potentially involved in spontaneous viral clearance by detecting the reactivity of the serum samples…”
Section: Discussionmentioning
confidence: 99%
“…In addition, fluoropeptides are stable and resistant to proteolytic degradation. The binding of an eight-carbon chain to either the amino or carboxyl terminus induces greater CD4+ and CD8+ T cell responses in mice than native peptides ( 31 ).…”
Section: Universal Influenza Vaccine Candidatesmentioning
confidence: 99%
“…The addition of F chain to peptides was applied in the development of vaccines as well. Thus, the presence of F chain in peptides derived from HIV, influenza and hepatitis C virus increased their cellular immunogenicity by controlling their ability to form micelles in solution [12] . More recently, we have shown that the conjugation of therapeutic peptides targeting GPCR with F chain provided a promising approach to enhance their plasma stability and in vivo activity [13] .…”
Section: Figurementioning
confidence: 99%